Natalie Sacks - Net Worth and Insider Trading

Natalie Sacks Net Worth

The estimated net worth of Natalie Sacks is at least $612,533 dollars as of 2024-11-13. Natalie Sacks is the Chief Medical Officer of Aduro Biotech Inc and owns about 34,744 shares of Aduro Biotech Inc (ADRO) stock worth over $507,262. Natalie Sacks is also the Chief Medical Officer of Harpoon Therapeutics Inc and owns about 4,575 shares of Harpoon Therapeutics Inc (HARP) stock worth over $105,271. Details can be seen in Natalie Sacks's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Natalie Sacks has not made any transactions after 2020-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Natalie Sacks

To

Natalie Sacks Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Natalie Sacks owns 5 companies in total, including Harpoon Therapeutics Inc (HARP) , Zymeworks Inc (ZYME) , and Aduro Biotech Inc (ADRO) among others .

Click here to see the complete history of Natalie Sacks’s form 4 insider trades.

Insider Ownership Summary of Natalie Sacks

Ticker Comapny Transaction Date Type of Owner
HARP Harpoon Therapeutics Inc 2020-05-18 Chief Medical Officer
ZYME Zymeworks Inc 2022-12-21 director
ADRO Aduro Biotech Inc 2018-09-13 Chief Medical Officer
LIMIT LIMIT 2016-08-31 Chief Medical Officer
LIMIT LIMIT 2021-07-22 director

Natalie Sacks Latest Holdings Summary

Natalie Sacks currently owns a total of 2 stocks. Among these stocks, Natalie Sacks owns 34,744 shares of Aduro Biotech Inc (ADRO) as of September 13, 2018, with a value of $507,262 and a weighting of 82.81%. Natalie Sacks also owns 4,575 shares of Harpoon Therapeutics Inc (HARP) as of May 18, 2020, with a value of $105,271 and a weighting of 17.19%.

Latest Holdings of Natalie Sacks

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADRO Aduro Biotech Inc 2018-09-13 34,744 14.60 507,262
HARP Harpoon Therapeutics Inc 2020-05-18 4,575 23.01 105,271

Holding Weightings of Natalie Sacks


Natalie Sacks Form 4 Trading Tracker

According to the SEC Form 4 filings, Natalie Sacks has made a total of 0 transactions in Aduro Biotech Inc (ADRO) over the past 5 years. The most-recent trade in Aduro Biotech Inc is the sale of 606 shares on September 13, 2018, which brought Natalie Sacks around $19,682.

According to the SEC Form 4 filings, Natalie Sacks has made a total of 14 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Harpoon Therapeutics Inc is the sale of 152 shares on May 18, 2020, which brought Natalie Sacks around $22,480.

Insider Trading History of Natalie Sacks

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Natalie Sacks Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Natalie Sacks Ownership Network

Ownership Network List of Natalie Sacks

No Data

Ownership Network Relation of Natalie Sacks

Insider Network Chart

Natalie Sacks Owned Company Details

What does Harpoon Therapeutics Inc do?

Who are the key executives at Harpoon Therapeutics Inc?

Natalie Sacks is the Chief Medical Officer of Harpoon Therapeutics Inc. Other key executives at Harpoon Therapeutics Inc include 10 percent owner Vijay K Lathi , Chief Medical Officer Luke Nathaniel Walker , and Principal Fin. & Acctng Ofc. Frank J Lanza .

Harpoon Therapeutics Inc (HARP) Insider Trades Summary

Over the past 18 months, Natalie Sacks made no insider transaction in Harpoon Therapeutics Inc (HARP). Other recent insider transactions involving Harpoon Therapeutics Inc (HARP) include a net purchase of 21,397,205 shares made by Merck & Co., Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Harpoon Therapeutics Inc (HARP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harpoon Therapeutics Inc (HARP) were sold and 21,397,205 shares were bought by its insiders, resulting in a net purchase of 21,397,205 shares.

Harpoon Therapeutics Inc (HARP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harpoon Therapeutics Inc Insider Transactions

No Available Data

Natalie Sacks Mailing Address

Above is the net worth, insider trading, and ownership report for Natalie Sacks. You might contact Natalie Sacks via mailing address: C/o Aduro Biotech, Inc., 740 Heinz Avenue, Berkeley Ca 94710.